1. Academic Validation
  2. Prenylated Flavonoids from the Roots and Rhizomes of Sophora tonkinensis and Their Effects on the Expression of Inflammatory Mediators and Proprotein Convertase Subtilisin/Kexin Type 9

Prenylated Flavonoids from the Roots and Rhizomes of Sophora tonkinensis and Their Effects on the Expression of Inflammatory Mediators and Proprotein Convertase Subtilisin/Kexin Type 9

  • J Nat Prod. 2019 Feb 22;82(2):309-317. doi: 10.1021/acs.jnatprod.8b00748.
Jongmin Ahn 1 Young-Mi Kim 2 Hee-Sung Chae 2 Young Hee Choi 2 Hee-Chul Ahn 2 Hunseung Yoo 3 Minseok Kang 3 Jinwoong Kim 1 Young-Won Chin 2
Affiliations

Affiliations

  • 1 College of Pharmacy and Research Institute of Pharmaceutical Sciences , Seoul National University , Seoul 08826 , Republic of Korea.
  • 2 College of Pharmacy and Integrated Research Institute for Drug Development , Dongguk University-Seoul , Gyeonggi-do 10326 , Republic of Korea.
  • 3 New Drug Preclinical & Analytical Team , Life Science R & D Center, SK Chemicals , 310 Pangyo-ro , Bundang-gu, Seongnam-si, Gyeonggi-do 13494 , Republic of Korea.
Abstract

Seven new prenylated Flavonoids (1-7) and one new prenylated phenylpropiophenone (8) were isolated from roots and rhizomes of Sophora tonkinensis, along with nine known compounds (9-17). The structures 1-8 were elucidated by spectroscopic data analysis and comparison with reported values. Compounds 8 and 12 (7-methoxyebenosin) showed inhibitory activities against nitric oxide production in lipopolysaccharide-induced RAW264.7 cells, with IC50 values of 8.1 and 6.2 μM, respectively. They also significantly lowered expression of CSF2, TNF, and IL-1β. Lonchocarpol A (10) and erybraedin D (16) at concentrations of 20 μM downregulated proprotein convertase subtilisin/kexin type 9 (PCSK9) mRNA expression in HepG2 cells. Moreover, erybraedin D (16) inhibited PCSK9 protein synthesis (IC50 7.8 μM), while simultaneously activating AMP-activated protein kinase and Acetyl-CoA Carboxylase.

Figures